scholarly article | Q13442814 |
P50 | author | Yunfei Yuan | Q40548428 |
P2093 | author name string | Tao Wang | |
Fudi Wang | |||
Dong Xie | |||
Xiao-Fan Wang | |||
Jing-Jing Li | |||
Yu-Xiong Feng | |||
Shu-Qun Cheng | |||
Jiang-Sha Zhao | |||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
Regulated cleavage of a contact-mediated axon repellent | Q28144522 | ||
Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade | Q28210840 | ||
The global health burden of infection-associated cancers in the year 2002 | Q28290871 | ||
Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map | Q28295221 | ||
Signalling pathways of the TNF superfamily: a double-edged sword | Q29616428 | ||
Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. | Q33256258 | ||
Inhibition of protein kinase B/Akt. implications for cancer therapy | Q34145575 | ||
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers | Q34290211 | ||
Tumor necrosis factor (TNF). | Q34378376 | ||
Eph and ephrin signaling in mammary gland morphogenesis and cancer | Q35676256 | ||
Nuclear factor-kappaB and liver carcinogenesis | Q36241968 | ||
Tumor necrosis factor: how to make a killer molecule tumor-specific? | Q36264840 | ||
Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility | Q36324074 | ||
Dysregulation of growth factor signaling in human hepatocellular carcinoma. | Q36519010 | ||
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome | Q36610209 | ||
Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease | Q37256387 | ||
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth | Q37682093 | ||
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway | Q40252238 | ||
Rac1 mediates intestinal epithelial cell apoptosis via JNK. | Q40263028 | ||
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. | Q40365399 | ||
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma | Q40423673 | ||
EphA2 expression is associated with aggressive features in ovarian carcinoma | Q40527994 | ||
Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application | Q40554993 | ||
Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization. | Q40612267 | ||
Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease | Q44476688 | ||
EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. | Q44822101 | ||
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection | Q45399300 | ||
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization | Q46699319 | ||
Cellular localization of ephrin-A2, ephrin-A5, and other functional guidance cues underlies retinotopic development across species. | Q48539184 | ||
Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases | Q60339438 | ||
Preoperative and postoperative cytokines in patients with cancer | Q67491499 | ||
Rac1-mediated endocytosis during ephrin-A2- and semaphorin 3A-induced growth cone collapse | Q74472748 | ||
Hepatocellular carcinoma | Q77355684 | ||
Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells | Q78330691 | ||
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update | Q79302506 | ||
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma | Q81128776 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | NF-κB | Q411114 |
liver cancer | Q623031 | ||
P304 | page(s) | 535-544 | |
P577 | publication date | 2010-02-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway | |
P478 | volume | 51 |
Q35783568 | Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling |
Q39644225 | Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E‐cadherin via the NF‐κB pathway |
Q34540458 | Design, synthesis, and in vitro and in vivo biological studies of a 3'-deoxythymidine conjugate that potentially kills cancer cells selectively |
Q40329185 | Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer |
Q21328694 | Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis |
Q36576644 | Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study |
Q39362601 | Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma |
Q45931466 | Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells. |
Q50002028 | Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA. |
Q31040344 | Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma |
Q46219683 | Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation |
Q34364217 | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma |
Q27323196 | Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines. |
Q27000047 | Research advances at the Institute for Nutritional Sciences at Shanghai, China |
Q37584993 | Roles of EphA2 in Development and Disease |
Q39601416 | Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model |
Q38150596 | The role of EPH receptors in cancer-related epithelial-mesenchymal transition |
Q39351169 | Tiam1 is associated with hepatocellular carcinoma metastasis |
Q45876952 | miR-21 Modulates the Immunoregulatory Function of Bone Marrow Mesenchymal Stem Cells Through the PTEN/Akt/TGF-β1 Pathway |
Search more.